Rad Viva provides dedicated CoreLab imaging support for clinical trials and research studies requiring structured, blinded, and standardized radiological analysis. Our radiologists work closely with sponsors, CROs, and academic institutions to ensure consistent endpoint reporting and regulatory compliance.
We specialize in high-quality imaging assessment for Phase I–IV trials across therapeutic areas, using globally accepted evaluation criteria.
Each imaging study is reviewed by qualified radiologists following pre-defined trial protocols. We support blinded and dual-reader models, quantitative measurements, time-point comparisons, and standardized criteria such as RECIST 1.1, mRECIST, PERCIST, and RANO.
Data is securely transferred and archived in compliance with Good Clinical Practice (GCP), with full documentation for audit and submission.
We support oncology, neurology, musculoskeletal, and metabolic trials involving CT, MRI, PET-CT, and DEXA imaging endpoints.
Yes. We offer single, dual-reader, and consensus reporting models with documented adjudication.
Yes. Reports and metrics can be structured for integration into trial management systems and electronic data capture (EDC) platforms.
Providing structured radiology reporting and CoreLab analysis for diagnostic centers, hospitals, and research organizations.
Email : info@radviva.com
Phone: +91-9844314454
Explore
Note: All services are provided remotely. Physical visits are not applicable.